LifeStance Health Group, Inc. (LFST)
USD 6.95
(-2.25%)
USD 6.95
(-2.25%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 491.23 Million USD | -8.54% |
| 2022 | 447.19 Million USD | -8.34% |
| 2021 | 487.86 Million USD | 47.51% |
| 2020 | 330.73 Million USD | 601.38% |
| 2019 | 47.15 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 88.83 Million USD | -3.84% |
| 2024 Q2 | 94.77 Million USD | 6.68% |
| 2023 Q1 | 103.69 Million USD | -4.61% |
| 2023 FY | 409 Million USD | -8.54% |
| 2023 Q4 | 92.38 Million USD | -38.64% |
| 2023 Q3 | 150.56 Million USD | 24.04% |
| 2023 Q2 | 121.38 Million USD | 17.06% |
| 2022 Q3 | 99.13 Million USD | -17.6% |
| 2022 Q2 | 120.3 Million USD | 1.05% |
| 2022 Q1 | 119.05 Million USD | -29.14% |
| 2022 FY | 447.19 Million USD | -8.34% |
| 2022 Q4 | 108.7 Million USD | 9.66% |
| 2021 Q1 | 44.87 Million USD | 28.1% |
| 2021 FY | 487.86 Million USD | 47.51% |
| 2021 Q4 | 168 Million USD | -4.93% |
| 2021 Q3 | 176.72 Million USD | 79.86% |
| 2021 Q2 | 98.25 Million USD | 118.93% |
| 2020 Q3 | 30.44 Million USD | 116.31% |
| 2020 Q2 | 14.07 Million USD | -11.13% |
| 2020 Q1 | 15.83 Million USD | 0.0% |
| 2020 FY | 330.73 Million USD | 601.38% |
| 2020 Q4 | 35.03 Million USD | 15.07% |
| 2019 FY | 47.15 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | -179.087% |
| Addus HomeCare Corporation | 248.92 Million USD | -97.345% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | -315.164% |
| Amedisys, Inc. | 834.47 Million USD | 41.133% |
| American Oncology Network, Inc. | 83.97 Million USD | -484.972% |
| Astrana Health, Inc. | 112.59 Million USD | -336.273% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 16.366% |
| IMAC Holdings, Inc. | 5.02 Million USD | -9671.587% |
| biote Corp. | 98.82 Million USD | -397.066% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -1295.325% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | -45.465% |
| COMPASS Pathways plc | 136.91 Million USD | -258.774% |
| DocGo Inc. | 180.32 Million USD | -172.41% |
| The Ensign Group, Inc. | 335.39 Million USD | -46.464% |
| Healthcare Services Group, Inc. | 189.09 Million USD | -159.784% |
| InnovAge Holding Corp. | 558.25 Million USD | 12.006% |
| Assure Holdings Corp. | 15.43 Million USD | -3081.748% |
| The Joint Corp. | 109.22 Million USD | -349.75% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -2592.834% |
| ModivCare Inc. | 586.89 Million USD | 16.301% |
| NewGenIvf Group Limited | 1.63 Million USD | -29861.398% |
| Novo Integrated Sciences, Inc. | 13.5 Million USD | -3537.157% |
| Option Care Health, Inc. | 666.62 Million USD | 26.311% |
| P3 Health Partners Inc. | 199.56 Million USD | -146.15% |
| P3 Health Partners Inc. | 199.56 Million USD | -146.15% |
| The Pennant Group, Inc. | 88.99 Million USD | -451.975% |
| Surgery Partners, Inc. | 319.5 Million USD | -53.75% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -11325.285% |
| Talkspace, Inc. | 97.58 Million USD | -403.366% |
| Talkspace, Inc. | 97.58 Million USD | -403.366% |
| The Oncology Institute, Inc. | 136.59 Million USD | -259.636% |
| The Oncology Institute, Inc. | 136.59 Million USD | -259.636% |